112 related articles for article (PubMed ID: 38372105)
21. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
22. Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
Chai RC; Zhang KN; Chang YZ; Wu F; Liu YQ; Zhao Z; Wang KY; Chang YH; Jiang T; Wang YZ
Carcinogenesis; 2019 Oct; 40(10):1229-1239. PubMed ID: 31157866
[TBL] [Abstract][Full Text] [Related]
23. A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma.
Xiao Y; Cui G; Ren X; Hao J; Zhang Y; Yang X; Wang Z; Zhu X; Wang H; Hao C; Duan H
Front Oncol; 2020; 10():605737. PubMed ID: 33381460
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analysis Identified Glycosyltransferase Signature to Predict Glioma Prognosis and TAM Phenotype.
Qi Y; Lv W; Liu X; Wang Q; Xing B; Jiang Q; Wang Z; Huang Y; Shu K; Lei T
Biomed Res Int; 2023; 2023():6082635. PubMed ID: 36685667
[TBL] [Abstract][Full Text] [Related]
25. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
Han Y; Xie Z; Zang Y; Zhang S; Gu D; Zhou M; Gevaert O; Wei J; Li C; Chen H; Du J; Liu Z; Dong D; Tian J; Zhou D
J Neurooncol; 2018 Nov; 140(2):297-306. PubMed ID: 30097822
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F
Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908
[TBL] [Abstract][Full Text] [Related]
27. Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.
Chen Z; Wu T; Yan Z; Zhang M
Front Cell Dev Biol; 2021; 9():652599. PubMed ID: 34249910
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma.
Xu S; Tang L; Liu Z; Luo C; Cheng Q
Front Immunol; 2021; 12():731048. PubMed ID: 34659218
[TBL] [Abstract][Full Text] [Related]
29. Identification and validation of RNA methylation-related alternative splicing gene signature for low-grade glioma to predict survival and immune landscapes.
Ma C; Bao Y; Xu J; Xiao B; Li H
J Cancer Res Clin Oncol; 2023 Jan; 149(1):47-62. PubMed ID: 36528831
[TBL] [Abstract][Full Text] [Related]
30. DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients.
Liu F; Tu Z; Liu J; Long X; Xiao B; Fang H; Huang K; Zhu X
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34988580
[TBL] [Abstract][Full Text] [Related]
31. Illustrating the biological functions and diagnostic value of transmembrane protein family members in glioma.
Zhang Y; Zhang W; Yuan Q; Hong W; Yin P; Shen T; Fang L; Jiang J; Shi F; Chen W
Front Oncol; 2023; 13():1145676. PubMed ID: 37064154
[TBL] [Abstract][Full Text] [Related]
32. Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma.
Chen Y; Wang Y; He Q; Wang W; Zhang T; Wang Z; Dong J; Lan Q; Zhao J
Cancer Med; 2021 Jul; 10(13):4644-4657. PubMed ID: 34121368
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of genes based on chr1p/19q co-deletion reveals a robust 4-gene prognostic signature for lower grade glioma.
Zhang C; Yu R; Li Z; Song H; Zang D; Deng M; Fan Y; Liu Y; Zhang Y; Qu X
Cancer Manag Res; 2019; 11():4971-4984. PubMed ID: 31213913
[No Abstract] [Full Text] [Related]
34. Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma.
Yu H; Gong M; Qi J; Zhao C; Niu W; Sun S; Li S; Hong B; Qian J; Wang H; Chen X; Fang Z
BMC Cancer; 2022 Aug; 22(1):885. PubMed ID: 35964070
[TBL] [Abstract][Full Text] [Related]
35. Cancer-associated fibroblast-associated gene IGFBP2 promotes glioma progression through induction of M2 macrophage polarization.
Zhang X; Sun X; Guo C; Li J; Liang G
Am J Physiol Cell Physiol; 2024 Jan; 326(1):C252-C268. PubMed ID: 37982173
[TBL] [Abstract][Full Text] [Related]
36. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
37. Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma.
Li J; Guo Q; Xing R
BMC Cancer; 2023 Aug; 23(1):727. PubMed ID: 37543576
[TBL] [Abstract][Full Text] [Related]
38. Prognostic characterization of the pyroptosis-related subtypes and tumor microenvironment infiltration in glioma.
He J; Zhou W; Zhang M
Cancer Biomark; 2023; 37(3):161-177. PubMed ID: 37248887
[TBL] [Abstract][Full Text] [Related]
39. Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.
Zeng WJ; Yang YL; Liu ZZ; Wen ZP; Chen YH; Hu XL; Cheng Q; Xiao J; Zhao J; Chen XP
Cell Physiol Biochem; 2018; 47(1):428-439. PubMed ID: 29794476
[TBL] [Abstract][Full Text] [Related]
40. GPGPS: a robust prognostic gene pair signature of glioma ensembling IDH mutation and 1p/19q co-deletion.
Cheng L; Wu H; Zheng X; Zhang N; Zhao P; Wang R; Wu Q; Liu T; Yang X; Geng Q
Bioinformatics; 2023 Jan; 39(1):. PubMed ID: 36637205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
